07:33 AM EST, 02/03/2025 (MT Newswires) -- Twist Bioscience ( TWST ) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.

Analysts polled by FactSet expected a loss of $0.68.

Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.

Analysts surveyed by FactSet expected $87 million.

The company said it expects fiscal Q2 revenue of $91 million to $93 million.

Analysts polled by FactSet expect $90.9 million.

For fiscal 2025, Twist Bioscience ( TWST ) raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.

Analysts polled by FactSet expect 373.3 million.